Trials / Completed
CompletedNCT00695864
Effect of Ondansetron for Withdrawal Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ondansetron and Placebo crossover |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-06-12
- Last updated
- 2017-05-15
- Results posted
- 2017-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00695864. Inclusion in this directory is not an endorsement.